DOCSLIB.ORG

Institute of the History of Medicine and Medical Ethics Chair of the History of Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Institute of the History of Medicine and Medical Ethics Chair of the History of Medicine CLINICAL THEORETICAL INSTITUTES Institute of the History of Medicine and Medical Ethics Chair of the History of Medicine Address matic perspective. Constitutional medicine be- ical professionals, especially regarding the defi- Glückstraße 10 fore, during, and after World War I and the nition of the normal and the pathological and - 91054 Erlangen emergence of statistical methods in medical re- during the 1920s - the limits of metrical Phone: +49 9131 8522308 search is studied in a habilitation project. Other methodologies. Fax: +49 9131 8522852 research is concerned with ancient medicine, www.igem.med.fau.de medicine in pre-modern times and medical his- Medical crime and the social torian museology. practice of terror – SS-physicians in Director concentration camps, 1934–1945 Prof. Dr. med. Karl-Heinz Leven 275 years Faculty of Medicine at FAU PI: Prof. Dr. K.-H. Leven, P. Rauh PI: Prof. Dr. K.-H. Leven, Dr. S. Ude-Koeller, P. Funding: Johannes and Frieda Marohn-Founda- Contact Rauh, A. Thum, Prof. Dr. R. Wittern-Sterzel tion, DFG (2013–2019) Prof. Dr. med. Karl-Heinz Leven Duration: 2016–2018 This project surveys the biographical develop- Phone: +49 9131 8522094 Funding: Faculty of Medicine ment of SS-physicians active in German concen- Fax: +49 9131 8522852 The project studied the chronological and struc- tration camps between 1934 and 1945, focus- [email protected] tural development of the Faculty of Medicine ing on their group-specific characteristics. Con- outlining its protagonists and prevalent interests sisting of two parts, the study aims at outlining Research focus before their scientific, cultural, social, and politic socialization, mentality, and actions, including • 275 years Faculty of Medicine at FAU backgrounds. A special focus rested on the 20th their role in concentration camps on the one • Constitutional medicine and medical theory, and beginning 21st centuries. Contemporary hand and their subsequent careers in both Ger- 1910–1930 history was approached by comprehensive use man states after 1945 on the other hand. In this • Medical crime and the social practice of terror: of oral history during which faculty members second part of the project, a well-defined group SS-physicians in concentration camps, 1934– underwent structured interviews. is employed to methodically analyze – for the 1945 first time – how both German states dealt with • NS-“euthanasia” in Erlangen: “T 4-Aktion” these people and their criminal past. and “B-Kost” • Galen – Compendium and catalogue of NS-“euthanasia” in Erlangen – Galenic writings “T 4-Aktion” and “B-Kost” • Receptions of ancient psychopathology PI: Prof. Dr. K.-H. Leven, Dr. S. Ude-Koeller • The German Society for Gynecology and Ob- The project examined a certain amount of cases stetrics under nazism of forced euthanasia (“T 4-Aktion”) and system- • Health and society in early modern Europe atic starvation to death (“B-Kost”) in Erlangen • Polish-German cooperation in the history of Heil- und Pflegeanstalt (Erlangen mental hospi- medicine • History of hospitals tal) during the Nazi regime from multiple per- • Medical history in objects – objects in the web spectives, both within its clinical context and • The world-wide correspondence of Johann the town of Erlangen. Until now unstudied Lukas Schönlein source material provided the basis for recon- structing both, the (criminal) acts of individuals Structure of the Chair or institutions and the life stories of their victims. Professorship: 1 Galen – Compendium and catalogue Personnel: 8 of Galenic writings • Doctor (of Medicine): 1 PI: Prof. Dr. K.-H. Leven • Scientists: 7 (thereof funded externally: 5) Cover of the Festschrift, published in 2018 The Greek physician Galenus of Pergamum • Graduate students: 8 (129–approximately 210 AD) figures as the Constitutional medicine and most influential medical author of the Roman Special structural feature medical theory, 1910–1930 imperial period. This research project aims at a The Chair of the History of Medicine and the PI: Dr. N. Metzger comprehensive depiction of Galenism both, in Professorship for Medical Ethics constitute the This habilitation project studies the modern its time of emergence and its impact on Institute of the History of Medicine and Medical constitutional medicine emerging since 1911 in medicine in the historical contexts. Furthermore Ethics. German-speaking countries and dominating an annotated catalogue of all remaining Galenic medical research of various disciplines during writings is devised. Research the 1920s. This interdisciplinary research pro- gram broached the issue of individual factors in Receptions of ancient Concerning modern medical history, research emergence and development of diseases in pa- psychopathology focuses on the history of medicine at FAU and tients’ bodies, thus promoting the wider intro- PI: Dr. N. Metzger the region up to the early 21st century. This in- duction of medical statistics into medical re- The look back to ancient medicine and its most cludes medicine in National Socialism which is search. Additionally, constitutional medicine fur- illustrious protagonists has been seminal to studied both from a prosopographical and the- thered discussion on medical theory with med- physicians, their learning and identity for cen- 64 turies. They have drawn onto ancient texts for Polish-German cooperation in the and Molecular Medicine. Each semester and in orientation, legitimation, and distancing, thus history of medicine collaboration with the Chair of Anatomy and using the ancient for their own purposes. Mad- PI: Prof. Dr. F. Dross Cell Biology, the interprofessional seminar ness is intertwined like no other medical con- Since 2005, the imately has been board mem- „Death and Dying in Cultural Perspective“ is cept with its cultural background, therefore re- ber of the German-Polish Association for the held. Furthermore, the wide range of teaching ception of ancient psychopathology is deeply History of Medicine. Main activities are biennial includes excursion seminars preparing field trips affected by new medical outlooks, epistemolog- joint conferences and the publication of the to the Flossenbürg KZ memorial site or the ical developments, and cultural surroundings conference proceedings. Deutsches Medizinhistorisches Museum Ingol- and can be used to line out the changing faces stadt. Regularly, seminars are held in conjunc- of medicine in history. History of hospitals tion with colleagues from the Faculty of Human- This project focuses on reception in Byzantine PI: Prof. Dr. F. Dross ities, Social Sciences, and Theology. late antiquity, early modern times, and the 19th The history of hospitals can be addressed as the We supervise MD theses. century. In all three epochs, fundamental social history of the distribution of medical care via and epistemological changes left their mark on large institutions. They serve as an essential Selected publications how physicians read their ancient counterparts. framework for modern medicine – the endpoint Frobenius W, Thum A, Dross F. Die Deutsche Gesellschaft Case studies include the medical encyclopedia of a long and intricate development since me- für Gynäkologie im Nationalsozialismus. Teile 1-4. in: Der of Paulos Nikaios (approximately 7th/9th AD), the dieval times. The PI is president of the German Frauenarzt 58 (2017), Nr. 2-4 early modern receptions of ancient illnesses Society for the History of Hospitals and editor of Metzger N. Es sind noch große Forschungserträge zu er- hoffen. Entwicklungen der Konstitutionslehre in den contributed by physicians to the contempora- its annual research journal “Historia Hospital- 1920er Jahren. in: Medizinhistorisches Journal 52 (2017): neous witchcraft debate (lycanthropy, incubus), ium”. 270-307 and trauma concepts in Byzantine late antiquity Dross F. Wallensteins Zipperlein. in: B. Emich, D. Niefanger, and 19th century medicine. Medical history in objects – D. Sauerer, G. Seiderer (Hg.), Wallenstein: Mensch - My- Objects in the web thos – Memoria. Berlin: Duncker & Humblot 2018: 253- The German Society for Gynecology PI: Prof. Dr. F. Dross 269 and Obstetrics under Nazism Funding: BMBF (2017–2020) Leven KH. Ethics and Deontology. In: Pormann PE (Hg.): The Cambridge Companion to Hippocrates. Cambridge PI: Prof. Dr. F. Dross, PD Dr. W. Frobenius, A. Funded by the BMBF, the academic collections 2018: 152-179 Thum (2016–2019) of FAU and the Germanische Nationalmuseum Leven KH, Rauh P, Thum A, Ude-Koeller S. Die Medizinische Under Nazism, the German Society for Gyne- Nuremberg joined to develop a shared strategy Fakultät der Friedrich-Alexander-Universität Erlangen-Nürn- cology acted as an agent between the official for making the objects in their collections digi- berg. Kontexte, Köpfe, Kontroversen (1743-2018). Wien, NS race and health policies, the involved gov- tally accessible. The Medical Collection Erlangen Köln, Weimar: Böhlau 2018 ernment authorities and party institutions, and preserves instruments and devices no longer Metzger N. Not a Daimon, but a Severe Illness. Oribasius, Posidonius and Later Ancient perspectives on superhuman their physician members. The society adapted needed in clinical practice, medical research, and agents causing disease. in: Mental Illness in Ancient Medi- to the changed powers and policies early on. education and is one of six university collections cine. From Celsus to Caelius Aurelianus. Singer P, Thumiger Their presidents functioned as communicational C (Hg.). Leiden: Brill 2018 (Studies in Ancient Medicine
Load more

Recommended publications
  • The Future Role of Molecular and Cell Biology in Medical Practice in the Tropical Countries
    The future role of molecular and cell biology in medical practice in the tropical countries David Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK Downloaded from https://academic.oup.com/bmb/article/54/2/489/285007 by guest on 27 September 2021 Molecular and cell biology have a great deal to offer tropical medicine in the future. As well as helping to understand the population genetics and dynamics of both infectious and non-infectious diseases, they promise to provide a new generation of diagnostic and therapeutic agents, and to play a major role in the development of new vaccines and other approaches to the control of disease in tropical communities. Over the last 20 years there has been a gradual shift in the emphasis of basic biomedical research from the study of disease in patients and their organs to its definition at the level of molecules and cells. This new trend has been underpinned by a remarkable new technology which has made it possible to isolate and sequence genes, study their function and transfer them across the species barrier. In the short time during which this field has evolved, a great deal has been discovered about human pathology at the molecular level. Many monogenic diseases have been characterised, much has been learnt about the molecular and cell biology of cancer, and a start has been made in defining the different genes that comprise the complex interactions between nature and nurture that underlie many of the major killers of Western society. Enough is known already to suggest that this knowledge will have major implications for the development of more precise diagnostic and therapeutic agents in the future.
    [Show full text]
  • Molecular Medicine Degree: Doctor of Philosophy (Phd)
    In the Name of God Islamic Republic of Iran Ministry of Health and Medical Education Deputy for Education Molecular Medicine Degree: Doctor of Philosophy (PhD) Total Course Credits Core: 24 Non-core (Electives): 6 Dissertation: 20 Program Description Although the concept of molecular medicine was introduced in 1949, a great deal of developments in this filed, especially in European and American countries, has taken place during recent years. Bearing in the mind the strategic significance of this area of knowledge, a considerable number of universities worldwide grant scholarships annually to students of this field of study. Iranian universities inaugurated Molecular Medicine in 2007 and due to the urgent escalating need for graduates of molecular medicine each year, an increasing number of universities receive students in this major. Molecular medicine, as an interdisciplinary field of study, contributes to understanding the molecular basis of the etiology and mechanisms of diseases and various disorders along with fundamental and heuristic research on different areas of diseases including prevention, diagnosis, and treatment. Dissemination of the science of molecular medicine through a blend of education and clinical research emphasizing active learning and up-to-date research will significantly contribute to the expansion of the borders of medicine and eventually improvement of health in society. Among the values of the field are practicing creativity and innovation to analyze lessons learned and research to utilize molecular medicine findings to solve problems related to public health. In this regard, graduates focus on social justice and human equality, the rights of patients, regardless of age, sex, color, race, culture and religion and any activity would be with regard to the protection of human dignity.
    [Show full text]
  • Systemic Lupus Erythematosus: Medlineplus Medical Encyclopedia 13/8/19 21:00
    Systemic lupus erythematosus: MedlinePlus Medical Encyclopedia 13/8/19 21:00 National Institutes of Health / U.S. National Library of Medicine Home → Medical Encyclopedia → Systemic lupus erythematosus URL of this page: //medlineplus.gov/ency/article/000435.htm Systemic lupus erythematosus Systemic lupus erythematosus (SLE) is an autoimmune disease. In this disease, the immune system of the body mistakenly attacks healthy tissue. It can afect the skin, joints, kidneys, brain, and other organs. Causes The cause of SLE is not clearly known. It may be linked to the following factors: Genetic Environmental Hormonal Certain medicines SLE is more common in women than men. It may occur at any age. However, it appears most often in people between the ages of 15 and 44. The disease afects African Americans and Asians more than people from other races. Symptoms Symptoms vary from person to person, and may come and go. Everyone with SLE has joint pain and swelling at some time. Some develop arthritis. SLE often afects the joints of the fingers, hands, wrists, and knees. Other common symptoms include: Chest pain when taking a deep breath. Fatigue. Fever with no other cause. General discomfort, uneasiness, or ill feeling (malaise). https://medlineplus.gov/ency/article/000435.htm Página 1 de 7 Systemic lupus erythematosus: MedlinePlus Medical Encyclopedia 13/8/19 21:00 Hair loss. Weight loss. Mouth sores. Sensitivity to sunlight. Skin rash: A "butterfly" rash develops in about half the people with SLE. The rash is mostly seen over the cheeks and bridge of the nose. It can be widespread. It gets worse in sunlight.
    [Show full text]
  • Medlineplus Connect?
    What is MedlinePlus Connect? What is MedlinePlus Connect? MedlinePlus Connect links health IT systems, patient portals and electronic health record (EHR) systems to relevant, authoritative health information (patient education) from MedlinePlus.gov. The National Library of Medicine, part of the National Institutes of Health, U.S. Department of Health and Human Services, provides this free service. MedlinePlus Connect is a Web application and a Web service that supports the HL7 Context-Aware Knowledge Retrieval (Infobutton) Knowledge Request Standard. What is MedlinePlus? How do patients or providers benefit from MedlinePlus? MedlinePlus.gov offers free, reliable, up-to-date health information in English and Spanish, with no advertisements. Content is from reputable providers, including the National Institutes of Health, and other government and professional organizations. MedlinePlus helps millions of visitors a year access: • Information on over 1,000 diseases, conditions and wellness topics • Videos and other multimedia • An illustrated medical encyclopedia • Medication and supplement information • Links to health information in over 60 languages • and much more… MedlinePlus.gov is your trusted source for health information. MedlinePlus Connect is a service bringing this reputable health information to patients, families, and health care providers when they need it via their patient portal or EHR. How does MedlinePlus Connect work? MedlinePlus Connect responds to requests based on diagnosis (problem) codes, medication codes, and laboratory
    [Show full text]
  • Summarization of an Online Medical Encyclopedia
    MEDINFO 2004 M. Fieschi et al. (Eds) Amsterdam: IOS Press © 2004 IMIA. All rights reserved Summarization of an Online Medical Encyclopedia Marcelo Fiszman, Thomas C. Rindflesch, Halil Kilicoglu National Library of Medicine, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA Marcelo Fiszman, Thomas C. Rindflesch, Halil Kilicoglu Abstract In this paper, we explore an abstraction methodology and apply it to multiple documents from an online medical encyclopedia. We explore a knowledge-rich (abstraction) approach to summa- We rely on a natural language processing system (called Sem- rization and apply it to multiple documents from an online med- Rep) and a transformation stage to produce conceptual conden- ical encyclopedia. A semantic processor functions as the source sates for disorder topics. We do not generate a summary text but interpreter and produces a list of predications. A transformation display the summarized information in graphical format. Final- stage then generalizes and condenses this list, ultimately gener- ly, we provide a preliminary evaluation of the quality of the con- ating a conceptual condensate for a given disorder topic. We densates produced for four disorders. provide a preliminary evaluation of the quality of the conden- sates produced for a sample of four disorders. The overall pre- cision of the disorder conceptual condensates was 87%, and the Background compression ratio from the base list of predications to the final Automatic Text Summarization Research condensate was 98%. The conceptual condensate could be used as input to a text generator to produce a natural language sum- The extraction paradigm focuses on identifying salient sentenc- mary for a given disorder topic.
    [Show full text]
  • Curriculum Resources
    NP/PA Clinical Hepatology Fellowship Curriculum Resources Hepatology Resources General Reference Manuals • Schiff E, Sorrell MF, Maddrey WC (Eds) Schiff's Diseases of the Liver. 11th edition. Philadelphia: Lippincott Williams and Wilkins, 2011. • Zakim D, Boyer TD (Eds): Hepatology. A Textbook of Liver Disease. WB Saunders, Philadelphia 2006. • Sherlock S, Dooley J (Eds). Diseases of the liver and biliary system. 11th Edition. Oxford: Blackwell Science, 2002. • Rodés J, Benhamou JP, Blei A, Reichen J, Rizzetto M (Eds.) Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd Edition 2007 Text & 2008 Online Aspinall RJ, Taylor- Robinson SD. Mosby's color atlas and text of gastroenterology and liver disease. Edinburgh; New York: Mosby, 2002. • Maddrey WC, Feldman M (Eds.). Atlas of the liver. Second Edition. Philadelphia: Current Medicine, 2000. • Madrey WC, Schiff ER, Sorrell MF (Eds). Transplantation of the liver. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins, 2000. • Ludwig J, Batts KP (Eds.). Practical liver biopsy interpretation: diagnostic algorithms. 2nd Edition. Chicago: ASCP Press, 1998. • Foundations of Clinical Research : Applications to Practice - 3rd edition Authors: Leslie Gross Portney. 2009. Publisher: Prentice Hall, Inc. • Kanel GC, Korula J (Eds.). Atlas of liver pathology. Philadelphia: W.B. Saunders, 1992 Online Aids for Disease Management • AASLD Practice Guidelines http://www.aasld.org/practiceguidelines/Pages/guidelinelisting.aspx • EASL Practice Guidelines http://www.aasld.org/practiceguidelines/Pages/guidelinelisting.aspx • Liver Learning www.liverlearning.org • Up To Date www.uptodate.com • MEDLINEplus Medical Encyclopedia www.nlm.nih.gov/medlineplus/encyclopedia.html • National Center for Infectious Diseases Viral Hepatitis Website www.cdc.gov/ncidod/diseases/hepatitis/index.htm (888-4HEP-CDC) • Essentials of Clinical Immunology http://www.immunologyclinic.com • The Internet Pathology Laboratory for Medical Education: Hepatic Pathology Images.
    [Show full text]
  • Getting to Know
    Getting to know 807777 f 02/10 Register on myCIGNA.com Nothing is more important than your good health. That’s why there’s www.myCIGNA.com – your online home for assessment tools, plan Getting to know management, medical updates and much more. Step 1 Step 2 Enter www.myCIGNA.com in the web Click on the Register button. address line on your browser. Step 3 Enter the required identification information, as noted with the asterisk. Your Member ID number is printed on your ID card. Step 4 Click on Register. Upon entering personal information a Confirmation Page should then appear. Click “Accept” if all information is accurate. 2 Navigation Overview HIGHLIGHTS: Visit myCIGNA – you can: That’s not all. You can access quality and cost n Find personal plan and claim information for certain procedures, tests and information. surgeries to help you make more informed decisions about where to receive care. Getting to know n Print a temporary ID card or request a new one. Use this guide to help find important features to n Get health care information. help you manage your health and make the most of your health plan. n Track total charges and what you pay out-of-pocket. Note: This guide is based on the experience of a typical user. Actual features may vary based on your plan and your individual security profile. n Plan for health expenses. Home My Plans Settings & Preferences Upon logging in, you’ll land on your Where most of your coverage Change your password, email address, personal Welcome Page where details are found.
    [Show full text]
  • Syllabus-Bio 656: Molecular Medicine and Mechanisms of Disease Fall 2016
    SYLLABUS-BIO 656: MOLECULAR MEDICINE AND MECHANISMS OF DISEASE FALL 2016 Friday 9:30-12:20 University Hall 444 Instructor: Dr. Julie Jameson Science Hall 1, Room 317 760-750-8274 [email protected] Office Hours: 9:30-10:30AM Wednesday and/or by appointment Final Exam: Combined oral presentation and written exam Dec 9 Course Description This course will provide an in-depth analysis of molecular medicine and advances in the field taught through a combination of didactic methods and the use of case studies. Topics will include basic principles of molecular medicine, discoveries in cellular and molecular biology, disease mechanisms and development, clinical research, biomedical ethics, and personalized medicine. An overview of the process from basic science discovery to therapeutic or vaccine approval is presented using practical aspects of specific historical examples. Lecture instruction may include understanding: how genes are used for personalized medicine, how current devices and therapeutics are used for the detection and treatment of cancer, how animal models of disease are used for pre-clinical studies, how cell-based therapeutics are used to eradicate disease, and how molecular medicine impacts global health. Prerequisites for BIOL 686-4: This class is only open to graduate students. Course Learning Outcomes At the end of the course students will be able to: 1. Understand and explain the organizational requirements for the translation of biomedical therapeutics from bench to bedside. 2. Debate the impact translational research has had on human health and disease. 3. Explain why pharmaceutical companies select particular drug or therapeutic targets for further study. 4. Articulate the significance and potential of molecular medical advances in biomedical research.
    [Show full text]
  • M Sc - Molecular Medicine
    Program M Sc - Molecular Medicine 1 Table of Contents Contents Pg. No. 1. PROGRAMME OUTCOMES 3 2. PROGRAMME EDUCATIONAL OBJECTIVES 4 3. CURRICULUM STRUCTURE 5 4. COURSE OBJECTIVES, COURSE OUTCOMES, SYLLABUS 7 2 PROGRAMME OUTCOMES Each graduate will be able to:- ● Develop a sound molecular understanding about the different diseases we encounter and how at molecular level one could tackle the issues to develop diagnostics and therapeutics for the betterment of healthcare. ● Student should be able to design strategies using molecular techniques taught to address issues pertaining to biotechnology development. ● Empower the student with capabilities that help them to take up transnationally oriented projects that help the society. ● Students have a wide option of choosing different medically oriented careers. ● Equip them to approach research confidently due to the hands on training of various techniques and writing manuscripts for publication. ● Student develops the skills to present their work in any forum for better projection of their work and biotechnology skills they acquired. ● As they are introduced to the translational aspects of medicine, they are better geared to innovate start-ups and transform themselves into entrepreneurs. 3 PROGRAMME EDUCATIONAL OBJECTIVES Molecular medicine is the study of molecular and cellular phenomena in biological systems, molecular aspects of human diseases, the human body’s response to diseases, heterogeneity of response and personalized medicine, stem cells, immune response and genetic determinants. The course covers the use of molecular understanding in discovery research in disease prevention, drug development, diagnosis and therapy. One of the unique strengths of this course is its emphasis on an interdisciplinary approach whereby medical sciences, molecular and biochemical aspects of biology is addressed.
    [Show full text]
  • Nuclear Medicine Inthe 21St Century: Integration with Other Specialties
    Nuclear Medicine in the 21st Century: Integration with Other Specialties Integration"—the watchword of the 1960s cine worked to set a name for itself as an inde "icivil rights movement, and now a catch pendent medical specialty. It had been left with a word of modern business management— few battle scars after making a break from radi "Now that we is also a concept becoming more and more fre ology. "During the 1970s, nuclear medicine quently used by nuclear medicine leaders, was trying to establish its own turf, and we were have established scientists and industry leaders. Just as academic always on the defensive," explained Wagner. "Now disciplines, telecommunications firms, hospitals, that we have established ourselves as a strong ourselves as a and other businesses have been merging and medical specialty, we need to integrate with other strong medical reconfiguring their organizations, many nuclear departments and develop relationships that can medicine physicians are contending that nuclear benefit the institution as well as the patient." At specialty, we medicine needs to integrate with other special Johns Hopkins, nuclear medicine has always been ties such as cardiology, oncology and surgery in part of the radiology department, but this part need to integrate, order to increase the demand for nuclear medi nership has grown stronger through the years as cine procedures in managed health care systems. the two specialties have developed a nearly and develop In essence, nuclear medicine can no longer be a symbiotic relationship. Recently, the department relationships separate-but-equal medical specialty. "Integra established a PET radiopharmaceutical net tion is the key to our future," asserted Henry N.
    [Show full text]
  • Graduate Student Guidelines
    Graduate Student Guidelines Molecular Medicine Matthew Potthoff, PhD Program Director Paulette Villhauer Program Administrator A subprogram of the Biomedical Science Graduate Program at The University of Iowa Roy J. and Lucille A. Carver College of Medicine The University of Iowa Revised 07/2018 Table of Contents I. Introduction…………………………………………………………………………………….……... 3 II. Program Administration……………………………………………………………………………... 3 A. Contacts………………………………………………………………………………………..…...… 3 B. When are You Required to Contact the Program Office?................................................…… 4 C. Whom Should you Contact?...........................................................................................……. 5 III. Financial Support…………………………………………………………………….……….…… 6-7 A. Training Grants……………………………………………………………………………….……… 6 B. Teaching Assistantships…………………………………………………………………….……… 7 C. Other Means of Support……………………………………………………………………..…….... 7 D. Summer Registration………………………………………………………………………………... 7 E. Tax Information………………………………………………………………………………………. 7 IV. Academic Standards………………………………………………………………......................... 7 A. Registration…………………………………………………………………................................... 7 B. Coursework…………………………………………………………………………………..………. 8 C. English Proficiency…………………………………………………………………………………... 8 D. Academic Standing………………………………………………………………………….………. 8 E. Laboratory and Seminar………………………………………………………...................……… 8 V. Supervision of Graduate Students,……………………………………………………….. ……… 9 A. Program Director…………………………………………………………………………….……….
    [Show full text]
  • Open This File in Your Browser
    Medical Fluids 2011; A(1): A9– A14 Fluids | ©2011 International Fluid Academy Proceedings: 1st iFAD Faculty 1st International Fluid Academy Day November 19, 2011, Elzenveld Congress and Convention Centre, Antwerp, Belgium At each International Fluid Academy Day a selected group of world-experts is invited to keep the partic- ipants up-to-date with regard to fluid management and hemodynamic monitoring. Below is an alpha- betical list of speakers for the 1st International Fluid Academy Days (IFAD) and the NURSING session with the ICU quiz. For each speaker a short bioprofile is given and a contact e-mail address should you wish to get in touch with him/her. Professor and Chief-Executive Director, Center for Sepsis Bakker Jan Control and Care, Jena University Hospital Rotterdam; The NetHerlands Research Interests and Areas of Supervision • Molecular Medicine • Mechanisms of organ failure • Genomics, Transcriptomics and Proteomics in systemic inflammation/ sepsis Curriculum vitae Aug 2010 – Professor (W3) and chief-executive director, Center for Sepsis Control and Care, Jena University Hospi- tal 2004 – 2010 Professor (C3) and vice chair, Department of Anesthesiology and Intensive Care Medicine, Jena Univer- sity Hospital 2001 - 2004 Vice chair, Department of Anesthesiology and Current work: Jan Bakker is working in the Erasmus MC Intensive Care Medicine, University of Saarland University Medical Center in the Department of Intensive 2000 Venia legendi for Clinical Anesthesiology, Medical Faculty of the University of Saarland Care Adults. He is Chair of the Department of Intensive 1999 Venia legendi for Experimental Anesthesiology, Care Adults, Chair division of Anesthesiology, Operating Medical Faculty of the University of Saarland Rooms, Intensive Care for Adults and Professor of Medi- 1998 - 1999 Visiting Adjunct Professor, Dept.
    [Show full text]